| 引用本文:汪受传1，孙轶秋1，卞国本2，徐玲3，马融4，王孟清5，刘光陵6.清肺口服液治疗小儿病毒性肺炎痰热闭肺证507例临床研究[J].世界中医药,2016,(09):. |
|
| 清肺口服液治疗小儿病毒性肺炎痰热闭肺证507例临床研究 |
| Clinical Study on Qingfei Oral Liquid Treating 507 Cases of Phlegm-heat Obstructing Lung Syndrome in Children Virus Pneumonia |
| 投稿时间：2016-09-09 |
| DOI：10.3969/j.issn.1673-7202.2016.09.001 |
| 中文关键词: 清肺口服液 小儿病毒性肺炎 痰热闭肺证 临床研究 |
| English Keywords:Qingfei Oral Liquid Children virus pneumonia Phlegm-heat obstructing lung syndrome Clinical study |
| 基金项目:江苏省社会发展计划项目（编号：BS96052）；“十五”国家科技攻关计划项目（编号：2001BA701A16b） |
|
| 摘要点击次数: 1238 |
| 全文下载次数: 1451 |
| 中文摘要: |
| 目的：观察清肺口服液治疗小儿病毒性肺炎痰热闭肺证的有效性、安全性。方法：以利巴韦林注射液为对照，采用清肺口服液治疗小儿病毒性肺炎痰热闭肺证，进行了两期6中心的507例随机对照临床试验。结果：两期临床研究的结果均表明：清肺口服液临床疗效显著优于利巴韦林注射液（P<0.05）：清肺口服液和利巴韦林注射液均未见明显的临床不良反应。结论：清肺口服液是治疗小儿病毒性肺炎痰热闭肺证有效而安全的药物。 |
| English Summary: |
| To study the effectiveness and safety of Qingfei Oral Liquid for phlegm-heat obstructing lung syndrome in children virus pneumonia.Methods:A total of 507 cases of phlegm-heat obstructing lung syndrome in children virus pneumonia were studied in two-stage and six-center randomized controlled clinical trials.Qingfei oral liquid was used in treat group，while ribavirin injection was used in control group.Results:Two-stage clinical trials showed that the effect of Qingfei Oral Liquid was significantly better than that of ribavirin injection(P<0.05).Conclusion:Qingfei Oral Liquid is effective and safe in treating phlegm-heat obstructing lung syndrome in children virus pneumonia. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
